CCK-81 Cells
CAD$690.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The CCK-81 cell line is a human colorectal adenocarcinoma model derived from a primary tumor. It is commonly used in cancer biology studies focusing on gastrointestinal malignancies and has been characterized for various genetic alterations and drug response profiles. According to functional screening of tumor suppressor genes, CCK-81 expresses mutant **TP53**, as confirmed by yeast-based functional assays, with only about 6% of colonies showing transcriptionally active p53 phenotype, indicating a loss-of-function mutation. This mutation status aligns with its tumorigenic origin and contributes to its relevance as a model for studying p53-deficient colorectal cancers. CCK-81 has also been included in major cancer cell line compendia such as the Cancer Cell Line Encyclopedia (CCLE), where it has been profiled across multiple omics layers including gene expression, copy number variation, mutation status, and drug sensitivity. Its inclusion in these datasets allows for integrated analyses of pathway dependencies and therapeutic vulnerabilities across colorectal cancer subtypes. For instance, proteogenomic profiling has highlighted that colorectal cancer cell lines, including CCK-81, often exhibit dysregulated signaling pathways such as Wnt/β-catenin and MAPK, making them suitable for precision oncology studies targeting these axes. |
|---|---|
| Organism | Human |
| Tissue | Metastatic |
| Disease | Colon adenocarcinoma |
| Synonyms | CCK81 |
Characteristics
| Age | 62 years |
|---|---|
| Gender | Female |
| Ethnicity | Japanese |
Regulatory Data
| Citation | CCK-81 (Cytion catalog number 305757) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2873 |
Biomolecular Data
| Mutational profile | Mutation: FBXW7, Simple, p.Arg465Cys (c.1393C>T), Heterozygous (DepMap=ACH-000963).Mutation, PIK3CA, Simple, p.Cys420Arg (c.1258T>C), Heterozygous (DepMap=ACH-000963).Mutation, TP53, Simple, p.Pro278His (c.833C>A), Heterozygous |
|---|
Handling
| Doubling time | 45 hours |
|---|---|
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
| Metastatic site: | Lymph node |
|---|